Meta-analysis of clinical efficacy and safety of JAK inhibitors in patients with moderate to severe COVID-19

DING Yi, LI Kun-fang, PENG Ao-xiang, LIU Nai-jie, LU Jia-hui, XUE Qing-jie, QU Yan-lin

Chinese Journal of Hospital Pharmacy ›› 2023, Vol. 43 ›› Issue (5) : 536-544.

PDF(10196 KB)
PDF(10196 KB)
Chinese Journal of Hospital Pharmacy ›› 2023, Vol. 43 ›› Issue (5) : 536-544. DOI: 10.13286/j.1001-5213.2023.05.12

Meta-analysis of clinical efficacy and safety of JAK inhibitors in patients with moderate to severe COVID-19

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 43(5): 536-544 https://doi.org/10.13286/j.1001-5213.2023.05.12

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(10196 KB)

Accesses

Citation

Detail

Sections
Recommended

/